IP Library › Granted Patent US 12,433,266
Granted Patent B2
US 12,433,266 · App. 18/110,276 · Granted Oct 7, 2025

Humanized light chain mice

Inventors: Lynn Macdonald (Harrison, NY); Cagan Gurer (Chappaqua, NY); Karolina A. Hosiawa (Yorktown Heights, NY); Sean Stevens (Del Mar, CA); Andrew J. Murphy (Croton-on-Hudson, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
A01K67/0278C07K16/2866C07K16/462C12N9/6489A01K2217/072A01K2217/15A01K2227/105A01K2267/01C12N2800/204C12N2800/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,433,266
App. No.
18/110,276
Granted
Oct 7, 2025
Kind
B2
Abstract

Non-human animals, tissues, cells, and genetic material are provided that comprise a modification of an endogenous non-human heavy chain immunoglobulin sequence and that comprise an ADAM6 activity functional in a mouse, wherein the non-human animals express a human immunoglobulin heavy chain variable domain and a cognate human immunoglobulin λ light chain variable domain.

Claims (26)

1. A method of making a genetically modified mouse embryonic stem(ES) cell, comprising genetically modifying the mouse ES cell so that its genome comprises:

(a) one or more human Vλ gene segments and one or more human Jλ gene segments upstream of a mouse immunoglobulin κ light chain constant region (Cκ),

(b) one or more human V H gene segments, one or more human D H gene segments, and one or more human J H gene segments upstream of a mouse immunoglobulin heavy chain constant region, and

(c) a nucleotide sequence that encodes a mouse ADAM6 protein, wherein the mouse ADAM6 protein is capable of restoring or enhancing fertility in a genetically modified male mouse.

2. The method of claim 1 , wherein the genome of the mouse ES cell comprises non-functional endogenous V L gene segments and/or endogenous J L gene segments.

3. The method of claim 1 , wherein the one or more human Vλ gene segments comprises at least 12 human Vλ gene segments.

4. The method of claim 1 , wherein the one or more human Vλ gene segments comprises at least 28 human Vλ gene segments.

5. The method of claim 1 , wherein the one or more human Vλ gene segments comprises at least 40 human Vλ gene segments.

6. The method of claim 1 , wherein the nucleotide sequence that encodes a mouse ADAM6 protein is positioned between two human V H gene segments.

7. The method of claim 1 , wherein the nucleotide sequence that encodes a mouse ADAM6 protein is positioned between a human V H gene segment and a human D H gene segment.

8. The method of claim 1 , wherein the one or more human Jλ gene segments are selected from the group consisting of Jλ1, Jλ2, Jλ3, Jλ7, and a combination thereof.

9. The method of claim 1 , wherein the one or more human Jλ gene segments comprises at least four human Jλ gene segments.

10. The method of claim 9 , wherein at least four human Jλ gene segments comprise at least Jλ1, Jλ2, Jλ3, and Jλ7.

11. The method of claim 1 , wherein all endogenous mouse Vκ gene segments and endogenous mouse Jκ gene segments are replaced with the one or more human Vλ gene segments and one or more human Jλ gene segments.

12. The method of claim 1 , wherein the mouse ES cell genome further comprises a human Vκ-Jκ intergenic region from a human κ light chain locus, wherein the human Vκ-Jκ intergenic region is contiguous with the one or more human Vλ gene segments and one or more human Jλ gene segments.

13. The method of claim 12 , wherein the human Vκ-Jκ intergenic region is placed between a human Vλ gene segment and a human Jλ gene segment.

14. The method of claim 12 , wherein the human Vκ-Jκ intergenic region comprises SEQ ID NO: 158.

15. The method of claim 1 , wherein the mouse ADAM6 protein is a mouse ADAM6a and/or ADAM6b protein.

16. The method of claim 1 , wherein the one or more human Vλ gene segments comprise Vλ3-1, Vλ4-3, Vλ2-8, Vλ3-9, Vλ3-10, Vλ2-11, Vλ3-12, or a combination thereof.

17. The method of claim 1 , wherein the one or more human Vλ gene segments comprise human Vλ2-14, Vλ3-16, Vλ2-18, Vλ3-19, Vλ3-21, Vλ3-22, Vλ2-23, Vλ3-25, Vλ3-27, or a combination thereof.

18. The method of claim 1 , wherein the one or more human Vλ gene segments comprise human Vλ1-40, Vλ7-43, Vλ1-44, Vλ5-45, Vλ7-46, Vλ1-47, Vλ9-49, Vλ1-51, Vλ5-52, or a combination thereof.

19. The method of claim 1 , wherein at least two λ light chain enhancers are located downstream of both the one or more human Vλ gene segments and the one or more human Jλ gene segments.

20. A genetically modified mouse embryonic stem(ES) cell comprising in its genome:

(a) one or more human Vλ gene segments and one or more human Jλ gene segments upstream of a mouse immunoglobulin κ light chain constant region (Cκ),

(b) one or more human V H gene segments, one or more human D H gene segments, and one or more human J H gene segments upstream of a mouse immunoglobulin heavy chain constant region, and

(c) a nucleotide sequence that encodes a mouse ADAM6 protein, wherein the mouse ADAM6 protein is capable of restoring or enhancing fertility in a genetically modified male mouse.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2025
From: MACDONALD, LYNN; GURER, CAGAN; HOSIAWA, KAROLINA A.; STEVENS, SEAN; MURPHY, ANDREW J.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 069961/0625 →
Continuity (5)
Continuation 16729852 · Dec 30, 2019
Continuation 15585023 · May 2, 2017
Division 13716238 · Dec 17, 2012
Provisional Application 61578097 · Dec 20, 2011
Related Publication 20230337646A1 · Oct 26, 2023
References Cited (400)
US 5545806A · Lonberg et al. · 1996 [cited by applicant]
US 5545807A · Surani et al. · 1996 [cited by applicant]
US 5658727A · Barbas et al. · 1997 [cited by applicant]
US 5942435A · Wheeler · 1999 [cited by applicant]
US 6162963A · Kucherlapati et al. · 2000 [cited by applicant]
US 6461818B1 · Bradley et al. · 2002 [cited by applicant]
US 6586251B2 · Economides et al. · 2003 [cited by applicant]
US 6596541B2 · Murphy et al. · 2003 [cited by applicant]
US 6632976B1 · Tomizuka et al. · 2003 [cited by applicant]
US 6657103B1 · Kucherlapati et al. · 2003 [cited by applicant]
US 6673986B1 · Kucherlapati et al. · 2004 [cited by applicant]
US 6774279B2 · Dymecki · 2004 [cited by applicant]
US 6998514B2 · Bruggemann · 2006 [cited by applicant]
US 7105348B2 · Murphy et al. · 2006 [cited by applicant]
US 7183076B2 · Arathoon et al. · 2007 [cited by applicant]
US 7435871B2 · Green et al. · 2008 [cited by applicant]
US 7501552B2 · Lonberg et al. · 2009 [cited by applicant]
US 7582298B2 · Stevens et al. · 2009 [cited by applicant]
US 7605237B2 · Stevens et al. · 2009 [cited by applicant]
US 7910798B2 · Tanamachi et al. · 2011 [cited by applicant]
US 7932431B2 · Bruggemann · 2011 [cited by applicant]
US 8158419B2 · Lonberg et al. · 2012 [cited by applicant]
US 8502018B2 · Murphy et al. · 2013 [cited by applicant]
US 8642835B2 · MacDonald et al. · 2014 [cited by applicant]
US 8697940B2 · Macdonald et al. · 2014 [cited by applicant]
US 9006511B2 · Macdonald et al. · 2015 [cited by applicant]
US 9012717B2 · Macdonald et al. · 2015 [cited by applicant]
US 9029628B2 · Macdonald et al. · 2015 [cited by applicant]
US 9035128B2 · MacDonald et al. · 2015 [cited by applicant]
US 9066502B2 · Macdonald et al. · 2015 [cited by applicant]
US 9150662B2 · Macdonald et al. · 2015 [cited by applicant]
US 9163092B2 · Macdonald et al. · 2015 [cited by applicant]
US 9206261B2 · Macdonald et al. · 2015 [cited by applicant]
US 9206262B2 · Macdonald et al. · 2015 [cited by applicant]
US 9206263B2 · Macdonald et al. · 2015 [cited by applicant]
US 9226484B2 · Macdonald et al. · 2016 [cited by applicant]
US 9334333B2 · Macdonald et al. · 2016 [cited by applicant]
US 9394373B2 · Macdonald et al. · 2016 [cited by applicant]
US 9399683B2 · Macdonald et al. · 2016 [cited by applicant]
US 9540452B2 · Macdonald et al. · 2017 [cited by applicant]
US 9622459B2 · Macdonald et al. · 2017 [cited by applicant]
US 9706759B2 · Macdonald et al. · 2017 [cited by applicant]
US 9844212B2 · Macdonald et al. · 2017 [cited by applicant]
US 9850462B2 · Macdonald et al. · 2017 [cited by applicant]
US 9932408B2 · Macdonald et al. · 2018 [cited by applicant]
US 9944716B2 · Macdonald et al. · 2018 [cited by applicant]
US 10072095B2 · Macdonald et al. · 2018 [cited by applicant]
US 10266803B2 · Macdonald et al. · 2019 [cited by applicant]
US 10561124B2 · Macdonald et al. · 2020 [cited by applicant]
US 10577430B2 · Macdonald et al. · 2020 [cited by applicant]
US 10694725B2 · Macdonald et al. · 2020 [cited by applicant]
US 11612151B2 · Macdonald et al. · 2023 [cited by applicant]
US 11617357B2 · Macdonald et al. · 2023 [cited by applicant]
US 20020026036A1 · Shitara et al. · 2002 [cited by applicant]
US 20020088016A1 · Bruggemann · 2002 [cited by applicant]
US 20020106628A1 · Economides et al. · 2002 [cited by applicant]
US 20020106629A1 · Murphy et al. · 2002 [cited by applicant]
US 20030108925A1 · Dix et al. · 2003 [cited by applicant]
US 20030109021A1 · Wu et al. · 2003 [cited by applicant]
US 20030217171A1 · Von Stuermer et al. · 2003 [cited by applicant]
US 20030217373A1 · Green et al. · 2003 [cited by applicant]
US 20040018626A1 · Murphy et al. · 2004 [cited by applicant]
US 20050060763A1 · Bruggeman et al. · 2005 [cited by applicant]
US 20060015957A1 · Lonberg et al. · 2006 [cited by applicant]
US 20060015958A1 · Kuroiwa et al. · 2006 [cited by applicant]
US 20060026696A1 · Buelow et al. · 2006 [cited by applicant]
US 20060083747A1 · Winter et al. · 2006 [cited by applicant]
US 20060106203A1 · Winter et al. · 2006 [cited by applicant]
US 20060199204A1 · Dix et al. · 2006 [cited by applicant]
US 20060257406A1 · Winter et al. · 2006 [cited by applicant]
US 20060280734A1 · Winter et al. · 2006 [cited by applicant]
US 20070280945A1 · Stevens et al. · 2007 [cited by applicant]
US 20080196922A1 · Van Marion et al. · 2008 [cited by applicant]
US 20080267982A1 · Kiselev et al. · 2008 [cited by applicant]
US 20090258392A1 · Gallo et al. · 2009 [cited by applicant]
US 20090271880A1 · Grosveld et al. · 2009 [cited by applicant]
US 20100069614A1 · Houtzager et al. · 2010 [cited by applicant]
US 20100146647A1 · Logtenberg et al. · 2010 [cited by applicant]
US 20110138489A1 · Tanamachi et al. · 2011 [cited by applicant]
US 20110145937A1 · MacDonald et al. · 2011 [cited by applicant]
US 20110195454A1 · McWhirter et al. · 2011 [cited by applicant]
US 20110236378A1 · Green et al. · 2011 [cited by applicant]
US 20110283376A1 · Murphy et al. · 2011 [cited by applicant]
US 20110314563A1 · Craig et al. · 2011 [cited by applicant]
US 20120021409A1 · McWhirter et al. · 2012 [cited by applicant]
US 20120047585A1 · Rohrer et al. · 2012 [cited by applicant]
US 20120070861A1 · Macdonald et al. · 2012 [cited by applicant]
US 20120073004A1 · MacDonald et al. · 2012 [cited by applicant]
US 20120096572A1 · Macdonald et al. · 2012 [cited by applicant]
US 20120167237A1 · Bradley et al. · 2012 [cited by applicant]
US 20120204278A1 · Bradley et al. · 2012 [cited by applicant]
US 20120272344A1 · Tanamachi et al. · 2012 [cited by applicant]
US 20120322108A1 · Macdonald et al. · 2012 [cited by applicant]
US 20130096287A1 · Macdonald et al. · 2013 [cited by applicant]
US 20130198879A1 · McWhirter et al. · 2013 [cited by applicant]
US 20130243759A1 · Friedrich et al. · 2013 [cited by applicant]
US 20130243773A1 · Van Berkel et al. · 2013 [cited by applicant]
US 20130263292A1 · Liang et al. · 2013 [cited by applicant]
US 20130263293A1 · Bradley et al. · 2013 [cited by applicant]
US 20130318643A1 · Bradley et al. · 2013 [cited by applicant]
US 20130323235A1 · Craig et al. · 2013 [cited by applicant]
US 20130323790A1 · Macdonald et al. · 2013 [cited by applicant]
US 20130326647A1 · Macdonald et al. · 2013 [cited by applicant]
US 20140137275A1 · Macdonald et al. · 2014 [cited by applicant]
US 20140213773A1 · Macdonald et al. · 2014 [cited by applicant]
US 20140283150A1 · Bradley et al. · 2014 [cited by applicant]
US 20150089680A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150173331A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150173332A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150176002A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150201589A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150210776A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150246976A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150246977A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150250152A1 · Jakobovits et al. · 2015 [cited by applicant]
US 20150320023A1 · Macdonald et al. · 2015 [cited by applicant]
US 20150351371A1 · Macdonald et al. · 2015 [cited by applicant]
US 20160057979A1 · Macdonald et al. · 2016 [cited by applicant]
US 20160060359A1 · Macdonald et al. · 2016 [cited by applicant]
US 20170107484A1 · Macdonald et al. · 2017 [cited by applicant]
US 20170258059A1 · Macdonald et al. · 2017 [cited by applicant]
US 20170332609A1 · Macdonald et al. · 2017 [cited by applicant]
US 20180064078A1 · Macdonald et al. · 2018 [cited by applicant]
US 20180345760A1 · Macdonald et al. · 2018 [cited by applicant]
US 20180346598A1 · Macdonald et al. · 2018 [cited by applicant]
US 20180346599A1 · Macdonald et al. · 2018 [cited by applicant]
US 20180362663A1 · Macdonald et al. · 2018 [cited by applicant]
US 20190153384A1 · Macdonald et al. · 2019 [cited by applicant]
US 20190203171A1 · Macdonald et al. · 2019 [cited by applicant]
US 20200221675A1 · Macdonald et al. · 2020 [cited by applicant]
US 20200221676A1 · Macdonald et al. · 2020 [cited by applicant]
CN 1203922A · 1999 [cited by applicant]
CN 1605628A · 2005 [cited by applicant]
CN 101002549A · 2007 [cited by applicant]
CN 101501073A · 2009 [cited by applicant]
CN 101657535A · 2010 [cited by applicant]
EA 010469 · 2008 [cited by applicant]
EA 010506B1 · 2008 [cited by applicant]
EP 1970448A1 · 2008 [cited by applicant]
JP H04500911A · 1992 [cited by applicant]
JP 2005510253A · 2005 [cited by applicant]
JP 2005224242A · 2005 [cited by applicant]
JP 2005230020A · 2005 [cited by applicant]
KR 19937002999 · 1993 [cited by applicant]
KR 1020030074634A · 2003 [cited by applicant]
KR 1020050042792A · 2005 [cited by applicant]
KR 20110125208A · 2011 [cited by applicant]
RU 2151612C1 · 2000 [cited by applicant]
RU 2264413C2 · 2005 [cited by applicant]
RU 010506U1 · 2008 [cited by applicant]
TW 201030143A · 2010 [cited by applicant]
WO WO9004036A1 · 1990 [cited by applicant]
WO WO9100906A1 · 1991 [cited by applicant]
WO WO9824893A2 · 1998 [cited by applicant]
WO WO0026373A1 · 2000 [cited by applicant]
WO WO00073323A2 · 2000 [cited by applicant]
WO WO0246237A2 · 2002 [cited by applicant]
WO WO0250120A2 · 2002 [cited by applicant]
WO WO0243478A2 · 2002 [cited by applicant]
WO WO02066630A1 · 2002 [cited by applicant]
WO WO03002609A2 · 2003 [cited by applicant]
WO WO03047336A2 · 2003 [cited by applicant]
WO WO2004049794A2 · 2004 [cited by applicant]
WO WO2004058820A2 · 2004 [cited by applicant]
WO WO2004058822A2 · 2004 [cited by applicant]
WO WO2005028510A2 · 2005 [cited by applicant]
WO WO2007096779A2 · 2007 [cited by applicant]
WO WO2007117410A2 · 2007 [cited by applicant]
WO WO2008015418A2 · 2008 [cited by applicant]
WO WO2008054606A2 · 2008 [cited by applicant]
WO WO2008076379A2 · 2008 [cited by applicant]
WO WO2009097006A2 · 2009 [cited by applicant]
WO WO2009143472A2 · 2009 [cited by applicant]
WO WO2010039900A2 · 2010 [cited by applicant]
WO WO2010070263A1 · 2010 [cited by applicant]
WO WO2011004192A1 · 2011 [cited by applicant]
WO WO2011072204A1 · 2011 [cited by applicant]
WO WO2011158009A1 · 2011 [cited by applicant]
WO WO2011163311A1 · 2011 [cited by applicant]
WO WO2011163314A1 · 2011 [cited by applicant]
WO WO2012018764A1 · 2012 [cited by applicant]
WO WO2012063048A1 · 2012 [cited by applicant]
WO WO2012141798A1 · 2012 [cited by applicant]
WO WO2013022782A1 · 2013 [cited by applicant]
WO WO2013041844A2 · 2013 [cited by applicant]
WO WO2013041845A2 · 2013 [cited by applicant]
WO WO2013041846A2 · 2013 [cited by applicant]
WO WO2013045916A1 · 2013 [cited by applicant]
WO WO2013061078A1 · 2013 [cited by applicant]
WO WO2013061098A2 · 2013 [cited by applicant]
WO WO2013079953A1 · 2013 [cited by applicant]
WO WO2013096142A1 · 2013 [cited by applicant]
WO WO2013116609A1 · 2013 [cited by applicant]
Lonberg N. (2005, Nature Biotechnology, vol. 23(9), pp. 1117-1125) (Year: 2005). [cited by examiner]
Janssens et al. (2006, PNAS, vol. 103(41), pp. 15130-15135) (Year: 2006). [cited by examiner]
Adams, D.J. et al., A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction, Genomics, 86(6):753-758 (2005). [cited by applicant]
Adderson, E.E. et al., Restricted Ig H Chain V Gene Usage in the Human Antibody Response to Haemophilus influenzae TYPE b Capsular Polysaccharide, The Journal of Immunology, 147:1667-1674 (1991). [cited by applicant]
Adderson, E.E. et al., Restricted Immunoglobulin VH Usage and VDJ Combinations in the Human Response to Haemophilus influenzae Type b Capsular Polysaccharide, Journal of Clinical Investigation, 91:2734-2743 (1993). [cited by applicant]
Alfandari, D. et al., Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration, Current Biology, 11:918-930 (2001). [cited by applicant]
Amit, M. and Itskovitz-Eldor, J., Embryonic Stem Cells: Isolation, Characterization and Culture, Adv Biochem Engin/Biotechnol, 114:173-184 (2009). [cited by applicant]
Appeal by Opponent for EP 12716101.6, 14 pages (Jun. 20, 2016). [cited by applicant]
Astellas Negotiates $295M License Extension to Regeneron's VelocImmune mAb Platform, GEN News Highlights, Jul. 28, 2010. [cited by applicant]
Austin, C. et al., The Knockout Mouse Project, Nat. Genet., 36(9):921-924 (2004). [cited by applicant]
Bando, Y. et al., Characterization of VH gene expressed in PBL from children with atopic diseases: detection of homologous VH1-69 derived transcripts from three unrelated patients, Immunology Letters, 94:99-106 (2004). [cited by applicant]
Baseggio, L. et al., CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases, Haematologica, 95(4):604-612 (20… [cited by applicant]
Bates, J.G. et al., Chromosomal position of a VH gene segment determines its activation and inactivation as a substrate for V(D)J recombination, Journal of Experimental Medicine, 204(13):3247-3256 (2007). [cited by applicant]
Berberian, L. et al., A VH Clonal Deficit in Human Immunodeficiency Virus-Positive Individuals Reflects a B-Cell Maturational Arrest, Blood, 78(1):175-179 (1991). [cited by applicant]
Blobel, Carl P., ADAMS: Key Components in EGFR Signalling and Development, Nature Reviews, Molecular Cell Biology, 6:32-43 (2005). [cited by applicant]
Borghei, A. et al., Targeted Disruption of Tyrosylprotein Sulfotransferase-2, an Enzyme That Catalyzes Post-translational Protein Tyrosine O-Sulfation, Causes Male Infertility, The Journal of Biological Chemistry, 281(1… [cited by applicant]
Brevini, T.A. et al., No shortcuts to pig embryonic stem cells, Theriogenology 74(4):544-550 (2010). [cited by applicant]
Brezinschek, H.P. et al., Analysis of the Heavy Chain Repertoire of Human Peripheral B Cells Using Single-Cell Polymerase Chain Reaction, Journal of Immunology, 155:190-202 (1995). [cited by applicant]
Brouwers, B. et al., Unexpected Phenotypes in Mouse Models Carrying the Human Growth Hormone Minigene to Enhance Transgene Expression, Journal of Steroids & Hormonal Science, 6(2): 2 pages (2015). [cited by applicant]
Brüggemann, M. and Neuberger, M.S., Strategies for expressing human antibody repertoires in transgenic mice, Immunol. Today, 17(8):391-7 (1996). [cited by applicant]
Bruggemann, M. et al., A repertoire of monoclonal antibodies with human heavy chains from transgenic mice, Proceedings of the National of Academy of Science USA, 86:6709-6713 (1989). [cited by applicant]
Bruggemann, M., Human Antibody Expression in Transgenic Mice, Archivum Immunologiae et Therapiae Experimentalis, 49:203-208 (2001). [cited by applicant]
Butler, J.E., Immunoglobulin diversity, B-cell and antibody repertoire development in large farm animals, Rev. Sci. Tech. Off. Int. Epiz., 17(1):43-70 (1998). [cited by applicant]
Canadian Office Action for Application No. 2,820,824, 3 pages, Aug. 5, 2014. [cited by applicant]
Carbonari, M, et al., Hepatitis C Virus Drives the Unconstrained Monoclonal Expansion of VH1-69-Expressing Memory B Cells in Type II Cryoglobulinemia: A Model of Infection-Driven Lymphomagenesis, The Journal of Immunolo… [cited by applicant]
Carson, S. and Wu, G.E., A linkage map of the mouse immunoglobulin lambda light chain locus, Immunogenetics, 29(3):173-9 (1989). [cited by applicant]
Cavelier P. et al., B lineage-restricted rearrangement of a human Ig kappa transgene, Eur J Immunol. 27(7):1626-31 (1997). [cited by applicant]
Chan, C.H. et al., VH1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen, Blood, 97(4):1023-1026 (2001). [cited by applicant]
Chang, S.P. et al., Immunologic memory to phosphocholine. IV. Hybridomas representative of Group I (T15-like) and Group II (non-T15-like) antibodies utilize distinct VH genes, J. Immunol., 132(3):1550-5 (1984). [cited by applicant]
Charles, E.D. et al., A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells, Journal of Immunological Methods, 363:210-220 (2011). [cited by applicant]
Cheval, L. et al., Of Mice and Men: Divergence of Gene Expression Patterns in Kidney, PLoS One, 7(10):e46876—12 pages (2012). [cited by applicant]
Chirino, A. et al., Minimizing the immunogenicity of protein therapeutics, DDT, 9(2):82-90 (2004). [cited by applicant]
Cho, C. et al., Analysis of Mouse Fertilin in Wild-Type and Fertilin ß-/- Sperm: Evidence for C-terminal Modification, al αl β Dimerization, and Lack of Essential Role of Fertilin α in Sperm-Egg Fusion, Developmental Bi… [cited by applicant]
Cho, C. et al., Fertilization Defects in Sperm from Mice Lacking Fertilin β, Science, 281:1857-1859 (1998). [cited by applicant]
Cho, Chunghee, Mammalian ADAMS with Testis-Specific or -Predominant Expression, The ADAM Family of Proteases, 239-259 (2005). [cited by applicant]
Cho, Chunghee, Testicular and epididymal ADAMS: expression and function during fertilization, Nat. Rev. Urol., 9:550-560 (2012). [cited by applicant]
Choi, H et al., Identification and characterization of promotor and regulatory regions for mouse [cited by applicant]
Choi, I. et al., Characterization and comparative genomic analysis of intronless Adams with testicular gene expression, Genomics, 83(4):636-46 (2004). [cited by applicant]
Choi, K. et al., Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice, PNAS, 108(37):15219-15224 (2011). [cited by applicant]
Clark, J. and Whitelaw, B., A future for transgenic livestock, National Reviews Genetics, 4(10):825-833 (2003). [cited by applicant]
Cocea, L. et al., A targeted deletion of a region upstream from the Jkappa cluster impairs kappa chain rearrangement in cis in mice and in the 103/bcl2 cell line, J Exp Med. 189(9):1443-50 (1999). [cited by applicant]
Combriato et al., Regulation of Human Igl Light Chain Gene Expression, The Journal of Immunology, 168: 1259-1266 (2002). [cited by applicant]
Communication in Cases for which No Other Form is Applicable for PCT/US2012/026416, 9 pages (Jun. 7, 2013). [cited by applicant]
Communication In Cases For Which No Other Form Is Applicable for PCT/US2012/069981, 18 pages (Jul. 3, 2013). [cited by applicant]
Communication pursuant to Article 114(2) EPC, dated Jun. 21, 2013. [cited by applicant]
Communication Relating to the Results of the Partial International Search for PCT/US2013/029624 (9 pages), mailed May 17, 2013. [cited by applicant]
Davidkova, G et al., Selective Usage of VH Genes in Adult Human B Lymphocyte Repertoires, Scandinavian Journal of Immunology, 45:62-73 (1997). [cited by applicant]
De Genst, E. et al., Antibody repertoire development in camelids, Development & Comparative Immunology, 30:187-198 (2006). [cited by applicant]
De Wildt, R. et al., Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire, J. Mol. Biol., 285(3):895-901 (1999). [cited by applicant]
Declaration of Dr. Glenn Friedrich, 4 page (Mar. 3, 2016). [cited by applicant]
Declaration of Dr. Jürgen Roes, Ph.D., 14 pages (Jul. 19, 2014). [cited by applicant]
Declaration of Dr. Kosuke Yusa and associated Annexes, 7 pages (Oct. 2, 2017). [cited by applicant]
Declaration of E-Chiang Lee, Ph.D., 8 pages (Jun. 20, 2016). [cited by applicant]
Declaration of Hui Liu, Ph.D., 4 pages (Jun. 20, 2016). [cited by applicant]
Declaration of Meng (Amy) Li, Ph.D., 4 pages (Jun. 20, 2016). [cited by applicant]
Declaration of Prof. Allan Bradley, Ph.D., 37 pages (Jun. 20, 2016). [cited by applicant]
Declaration of Wei Wang, Ph.D., 8 pages (Jun. 20, 2016). [cited by applicant]
Dudley, D.D et al., Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences, Adv. Immunol., 86:43-112 (2005). [cited by applicant]
Edwards D.R. et al., The ADAM metalloproteinases, Molecular Aspects of Medicine, 29(5):258-89 (2008). [cited by applicant]
Enever, C et al., Next generation immunotherapeutics—honing the magic bullet, Current Opinion in Biotechnology, 20(4):405-11 (2009). [cited by applicant]
Ensembl database entries for the heavy and light chain immunoglobulin loci, as submitted in EP 2550363 on Oct. 16, 2017, 3 pages. [cited by applicant]
European Examination Report for EP 14154967.5, Sep. 9, 2014, 4 pages. [cited by applicant]
European Office Action for 12 716 101.6-1410, 5 pages, Jun. 17, 2014. [cited by applicant]
European Search Report for EP12195716, 15 pages (Feb. 4, 2013). [cited by applicant]
European Search Report for EP12195716, 15 pages (Jan. 29, 2013). [cited by applicant]
Extended European Search Report for 12192727.1, 8 pages (Mar. 7, 2013). [cited by applicant]
Extended European Search Report for 14154918.8, 8 pages (Aug. 27, 2014). [cited by applicant]
Extended European Search Report for 14176593.3, 10 pages (Nov. 19, 2014). [cited by applicant]
Farner, N. et al., Molecular Mechanisms and Selection Influence the Generation of the Human VλJλ Repertoire, The Journal of Immunology, 162:2137-2145 (1999). [cited by applicant]
Featherstone, K. et al., The mouse immunoglobulin heavy chain V-D intergenic sequence contains insulators that may regulate ordered V(D)J recombination, J. Biol. Chem. 285(13):9327-9338 (2010). [cited by applicant]
Gallo et al., U.S. Pat. No. 20090258392 A1, Oct. 15, 2009—Seq Id No. 112 alignment with Seq Id No. 100 of 13166200. [cited by applicant]
Gama Sosa, M.A. et al., Animal transgenesis: an overview, Brain Structure & Function, 214(2-3):91-109 (2010). [cited by applicant]
Gaultier, A. et al., ADAM13 Disintegrin and Cysteine-rich Domains Bind to the Second Heparin-binding Domain of Fibronectin, The Journal of Biological Chemistry, 277(26):23336-23344 (2002). [cited by applicant]
GenBank accession No. NT_114985, p. 1, first referenced Dec. 1, 2005, last updated Feb. 9, 2015. [cited by applicant]
Giallourakis, C.C. et al., Elements between the IgH variable (V) and diversity (D) clusters influence antisense transcription and lineage-specific V(D)K recombination, PNAS, 107(51):22207-22212 (2010). [cited by applicant]
Glassey, B. and Civetta, A., Positive Selection at Reproductive ADAM Genes with Potential Intercellular Binding Activity, Molecular Biology and Evolution, 21(5): 851-859 (2004). [cited by applicant]
Glassy, M. et al., Final Oral Progamme, The Twelfth International Conference on Human Antibodies & Hybridomas, 4 pages (May 10-12, 2006). [cited by applicant]
Glassy, M et al., Second Circular and Provisional Conference Program, The Twelfth International Conference on Human Antibodies & Hybridomas, 8 pages (May 10-12, 2006). [cited by applicant]
Glik, B. Molecular Biotechnology, Moscow. Mir., pp. 211-212, 429-433 (2002). [cited by applicant]
Goni, F. et al., Sequence similarities and cross-idiotypic specificity of L chains among human monoclonal IgM kappa with anti-gamma-globulin activity, The Journal Immunology, 135(6):4073-9 (1985). [cited by applicant]
Gorman, et al., The LGK 3′ Enhancer Influences the Ratio of LGK Versus LGL B Lymphocytes, Immunity, 5(3): 241-252(1996). [cited by applicant]
Gorman, J.R. et al., The Ig(kappa) enhancer influences the ratio of Ig (kappa) versus Ig(lambda) B lymphocytes, Immunity 5(3):241-252 (1996). [cited by applicant]
Grawunder, U. et al., Induction of sterile transcription from the kappa L chain gene locus in V(D)J recombinase-deficient progenitor B cells, International Immunology 7(12):1915-1925 (1995). [cited by applicant]
Green, L. et al., Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs, Nature Genetics, 7(1):13-21 (1994). [cited by applicant]
Hagaman, J. et al., Angiotensin-covering enzyme and male fertility, Proc. Natl. Acad. Sci. USA, 95:2552-2557 (1998). [cited by applicant]
Han, C. et al., Comprehensive analysis of reproductive ADAMs: relationship of ADAM4 and ADAM6; with an ADAM complex required for fertilization in mice, Biology of Reproduction, 80(5): 1001-8 (2009). [cited by applicant]
Han, C. et al., Impaired sperm aggregation in [cited by applicant]
Hatton, K. and Schildkraut, C., The Mouse Innunoglobulin Kappa Light-Chain Genes Are Located in Early- and Late-Replicating Regions of Chromosome 6, Molecular and Cellular Biology, 10(8):4314-4323 (1990). [cited by applicant]
Hendricks J et al., Organization of the variable region of the immunoglobulin heavy-chain gene locus of the rat, Immunogenetics, 62(7):479-86 (2010). [cited by applicant]
Hirohata, S. et al., Chromosomal Assignment of Two ADAM Genes, TACE (ADAM17) and MLTNB (Adam 19), to Human Chromosomes 2 and 5, Respectively, and of Mitnb to Mouse Chromosome 11, Genomics, 54:178-179 (1998). [cited by applicant]
Hoiruchi, K. and Blobel, C., Studies From ADAM Knockout Mice, The ADAM Family of Proteases, 29-64 (2005). [cited by applicant]
Huang, C. and Stoller, B.D., A Majority of Ig H Chain cDNA of Normal Human Adult Blood Lymphocytes Resembles cDNA for Fetal Ig and Natural Autoantibodies, The Journal of Immunology, 151(10):5290-5300 (1993). [cited by applicant]
Huovila, A. et al., ADAMs and cell fusion, Current Opinion in Cell Biology, 8:692-699 (1996). [cited by applicant]
Hussack, G. et al., “A VL single-domain antibody library shows a high-propensity to yield non-aggregating binders,” Protein Engineering, Design & Selection, 25(6):313-318 (2012). [cited by applicant]
Ignatovich, O. et al., Dominance of Intrinsic Genetic Factors in Shaping the Human Immunoglobulin Vλ Repertoire, J. Mol. Biol., 294:457-465 (1999). [cited by applicant]
Ignatovich, O. et al., The Creation of Diversity in the Human Immunoglobulin Vλ Repertoire, J. Mol. Biol., 268:69-77 (1997). [cited by applicant]
Ikawa, M. et al., Calsperin Is a Testis-specific Chaperone Required for Sperm Fertility, The Journal of Biological Chemistry, 286(7):5639-5646 (2011). [cited by applicant]
Ill, C.R. et al., Design and construction of a hybrid immunoglobulin domain with properties of both heavy and light chain variable regions, Protein Engineering, 10(8):949-57 (1997). [cited by applicant]
Immler, S. et al., By Hook or by Crook? Morphometry, Competition and Cooperation in Rodent Sperm, PLoS ONE, Issue 1(e170) 5 pages (2007). [cited by applicant]
Immler, Simone, Sperm competition and sperm cooperation: the potential role of diploid and haploid expression, Reproduction, 135:275-283 (2008). [cited by applicant]
Interlocutory decision in Opposition proceedings (Art. 101(3)(a) and 106(2) EPC) for EP12716101.6, 36 pages (May 26, 2017). [cited by applicant]
International Search Report and Written Opinion for PCT/US2011/046196, 13 pages (Oct. 17, 2011). [cited by applicant]
International Search Report and Written Opinion for PCT/US2013/024295, 12 pages (Apr. 24, 2013). [cited by applicant]
International Search Report for PCT/US2011/041366, 5 pages (Sep. 22, 2011). [cited by applicant]
International Search Report for PCT/US2011/041370, 5 pages (Sep. 22, 2011). [cited by applicant]
International Search Report for PCT/US2012/026416, 4 pages (Jun. 25, 2012). [cited by applicant]
International Search Report for PCT/US2012/060487, 7 pages (Feb. 1, 2013). [cited by applicant]
International Search Report for PCT/US2012/069981, 5 pages (Mar. 20, 2013). [cited by applicant]
International Search Report for PCT/US2013/029624, 9 pages (Aug. 2, 2013). [cited by applicant]
Jakobovits, A., Production of fully human antibodies by transgenic mice, Current Opinion in Biotechnology, 6:561-566 (1995). [cited by applicant]
Janeway, C.A., et al., Immunobiology: The Immune System in Health and Disease, 5th Edition, Chapter 9, New York, Garland Science, 2 pages (2001). [cited by applicant]
Janssens, R. et al., “Generation of heavy-chain-only antibodies in mice,” Proceedings of the National Academy of Sciences, 103(41):15130-15135 (2006). [cited by applicant]
Janssens, R. et al., Generation of heavy-chain-only antibodies in mice, Proc Natl Acad Sci USA, 103(41):15130-5 (2006). [cited by applicant]
Johnson, T.A. et al., Ig VH1 Genes Expressed in B Cell Chronic Lymphocytic Leukemia Exhibit Distinctive Molecular Features, The Journal of Immunology, 158:235-246 (1997). [cited by applicant]
Johnston, C. et al., Complete Sequence Assembly and Characterization of the C57BL/6 Mouse Ig Heavy Chain V Region, The Journal of Immunology, 176:4221-4234 (2006). [cited by applicant]
Kaartinen, M. et al., Combinatorial association of V genes: one VH gene codes for three non-cross-reactive monoclonal antibodies each specific for a different antigen (phoxazolone, NP or gat), Molecular Immunology, 25(9… [cited by applicant]
Kabat, E.A., and Wu, T.T., Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determinin… [cited by applicant]
Kantor, A.B. et al., An Unbiased Analysis of VH-D-JH Sequences from B-1a, B-1b, and Conventional B Cells, The Journal of Immunology, 158:1175-1186 (1997). [cited by applicant]
Karow, Margaret, Making the VelocImmune mouse using Velocigene technology [abstract], Session 5: Molecular biology—II, Human Antibodies, 15:19-28 (2006). [cited by applicant]
Kaushik, A. et al., Novel insight into antibody diversification from cattle, Veterinary Immunology and Immunopathology 87(3-4):347-350 (2002). [cited by applicant]
Kim T. et al., Expression and relationship of male reproductive ADAMs in mouse, Biology of Reproduction, 74(4):744-50 (2006). [cited by applicant]
Kim, E. et al., Differential localization of ADAM1a and ADAM1b in the endoplasmic reticulum of testicular germ cells and on the surface of epididymal sperm, Biochemical and Biophysical Research Communications, 304:313-3… [cited by applicant]
Kim, E. et al., Mouse Sperm Lacking ADAM1b/ADAM2 Fertilin Can Fuse with the Egg Plasma Membrane and Effect Fertilization, The Journal of Biological Chemistry, 281(9):5634-5639 (2006). [cited by applicant]
Kim, E. et al., Synthesis, Processing, and Subcellular Localization of Mouse ADAM3 during Spermatogenesis and Epididymal Sperm Transport, Journal of Reproduction and Development, 50(5):571-578 (2004). [cited by applicant]
Kingzette, M. et al., Trans-chromosomal recombination within the Ig heavy chain switch region in B lymphocytes, Proceedings of the National Academy of Sciences of the USA, 95(20):11840-11845 (1998). [cited by applicant]
Klebig, M. L., Ectopic Expression of the Agouti Gene in Transgenic Mice Causes Obesity, Features of Type II Diabetes, and Yellow Fur, Proc. Natl. Acad. Sci. USA, vol. 92, pp. 4728-4732, (1995). [cited by applicant]
Kong et al., Transgene expression is associated with copy number and cytomegalovirus promoter methylation in transgenic pigs, PLoS One 4(8):1-10 (2009). [cited by applicant]
Krutskikh, A. et al., Epididymal protein Rnase10 is required for post-testicular sperm maturation and male fertility, The FASEB Journal, 26(10): 4198-4209 (2012). [cited by applicant]
Kunert, R. et al., Characterization of Molecular Features, Antigen-Binding, and in Vitro Properties of IgG and IgM Variants of 4E10, an Anti-HIV Type 1 Neutralizing Monoclonal Antibody, Aids Research and Human Retroviru… [cited by applicant]
Kuroiwa, Y. et al., Sequential targeting of the genes encoding immunoglobulin-μ and prion protein in cattle, Nature Genetics, 36:775-780 (2004). [cited by applicant]
Lavial, F. and Pain B., Chicken embryonic stem cells as a non-mammalian embryonic stem cell model, Develop. Growth Diff. 52(1):101-114 (2010). [cited by applicant]
Leclercq, L., et al., A novel germ-line JK transcript starting immediately upstream of JK1, Nucleic Acids Research 17(17):6809-6819 (1989). [cited by applicant]
Lee, E. et al., Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery, Nature Biotechnology, 32:4:356, 12 pages (2014). [cited by applicant]
Lefranc, M.P., Nomenclature of the human immunoglobulin lambda (IGL) genes, Experimental and clinical immunogenetics, S. Karger Basel C.H., 18(4):242-254 (2001). [cited by applicant]
Lefranc, M.P., Nomenclature of the Human Immunoglobulin Genes Current Protocols in Immunology, Supplement 40:A.1P.1-A.1P.37 (2000). [cited by applicant]
Lefranc, M-P. and Lefranc, G., Immunoglobulin Lambda (IGL) Genes of Human and Mouse, Molecular Biology of B Cells, London: Elsevier Academic Press, Eds. Honjo, T et al., Chapter 4, pp. 37-59 (2004). [cited by applicant]
Leitzgen, K et al., Assembly of immunoglobulin Light Chains as a Prerequisite for Secretion, Journal of Biological Chemistry, 272(5):3117-3123 (1997). [cited by applicant]
Lin, P. et al., Research of Immune Globulin in Mice, Guangzhou Medical Journal, 01:49-50 (1990). [cited by applicant]
Linder, B. et al., Delayed Translation and Posttranslational Processing of Cyritestin, an Integral Transmembrane Protein of the Mouse Acrosome, Experimental Cell Research, 221:66-72 (1995). [cited by applicant]
Liu, Y. et al., Primary Genetic Investigation of a Hyperlipidemia Model: Molecular Characteristics and Variants of the Apolipoprotein E Gene in Mongolian Gerbil, Biomed Research International, 2014: 9 pages (2014). [cited by applicant]
Lonberg, N., Human antibodies from transgenic animals, Nature Biotechnology, 23(9):1117-1125 (2005). [cited by applicant]
Long, J. et al., Phylogenetic and molecular evolution of the ADAM (A Disintegrin and Metalloprotease) gene family from Xenopus tropicalis, to Mus musculus, Rattus norvegicus, and [cited by applicant]
Lovell-Badge, Robin, Many ways to pluripotency, Nature Biotechnology, 25:1114-1116 (2007). [cited by applicant]
MacDonald, L. et al., Velocigene Technology Extended to Humanization of Several Megabases of Complex Gene Loci, First International MUGEN Conference of Animal Models for Human Immunological Disease, Sep. 10-13, 2006—Ath… [cited by applicant]
Mageed, R.A. et al., Rearrangement of the human heavy chain variable region gene V3-23 in transgenic mice generates antibodies reactive with a range of antigens on the basis of VHCDR3 and residues intrinsic to the heavy… [cited by applicant]
Mahmoud, T.L et al., Limiting CDR-H3 Diversity Abrogates the Antibody Response to the Bacterial Polysaccharide x 1→3 Dextran, The Journal of Immunology, 187:879-886 (2011). [cited by applicant]
Mahmoudi, M. et al., V region gene analysis of human IgM hybridoma monoclonal anti-Sm antibodies, Lupus, 6:578-589 (1997). [cited by applicant]
Manis, J.P. et al., Mechanism and control of class-switch recombination, Trends. Immunol., 23(1):31-9 (2002). [cited by applicant]
Marasca, R. et al., Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell Lymphoma, American Journal of Path… [cited by applicant]
Marcello, M. et al., Lack of tyrosylprotein sulfotransferase-2 activity results in altered sperm-egg interactions and loss of ADAM3 and ADAM6 in epididymal sperm, J Biol Chem, 286(15):13060-13070 (2011). [cited by applicant]
Mar. 3, 2016 Letter from H. Van Der Hoff, Opposition against EP 2550363 (2 pages). [cited by applicant]
Martin, D.J., and Van Ness, B.G. Identification of a Germ Line Transcript from the Unrearranged Kappa Gene in Human B Cells, Molecular and Cellular Biology 9(10)4560-4562 (1989). [cited by applicant]
Martin, D.J., and Van Ness, B.G. Initiation and Processing of Two Kappa Immunoglobulin Germ Line Transcripts in Mouse B cells, Molecular and Cellular Biology 10(5):1950-1958 (1990). [cited by applicant]
McGoldrick, P. et al., Rodent models of amyotrophic lateral sclerosis, Biochimica et Biophysica Acta, 1832:1421-1436 (2013). [cited by applicant]
Mei, S.et al., Vasoactive intestinal peptide hydrolysis by antibody light chains, The Journal of Biological Chemistry, 266(24):15571-4 (1991). [cited by applicant]
Melton, David W., Chapter 8: Gene-Targeting Strategies, Methods in Molecular Biology, Transgenesis Techniques, 2nd Edition, Principles and Protocols, 180:19 pages (2002). [cited by applicant]
Miklos, J.A. et al., Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin VH genes show frequent use of V1-69 with distinctive CDR3 features, Blood, 95:3878-3884 (2000). [cited by applicant]
Mills, F. et al., Enhancer complexes located downstream of both human immunoglobulin Calpha genes, Journal of Experimental Medicine, 186(6): 845-58 (1997). [cited by applicant]
Minutes of the taking of evidence by hearing of witnesses recorded in the oral proceedings before the Opposition Division for EP12716101.6, 25 pages (May 26, 2017). [cited by applicant]
Montaño, R.F. and Morrison, S.L., Influence of the Isotype of the Light Chain on the Properties of IgG, Journal of Immunology, 168:224-231 (2002). [cited by applicant]
Moore, H et al., Exceptional sperm cooperation in the wood mouse, Nature, 418:174-177 (2002). [cited by applicant]
Moran N., Mouse platforms jostle for slice of humanized antibody market, Nature Biotechnology, 31(4): 267-268, (2013). [cited by applicant]
Morrison, S.L. et al., Variable region domain exchange influences the functional properties of IgG, Journal of Immunology, 160(6):2802-8 (1999). [cited by applicant]
Mortari, F. et al., Human Cord Blood Antibody Repertoire, The Journal of Immunology, 150(4):1348-1357 (1993). [cited by applicant]
Muller, S. et al., B-Cell Abnormalities in AIDS: Stable and Clonally-Restricted Antibody Response in HIV-1 Infection, Scandinavian Journal of Immunology, 38:327-334 (1993). [cited by applicant]
Muñoz, M. et al., Conventional pluripotency markers are unspecific for bovine embryonic-derived cell-lines, Theriogenology 69(9):1159-1164 (2008). [cited by applicant]
Murphy, A., Declaration Under 37 C.F.R. §1.132, 4 pages (2014). [cited by applicant]
Murphy, Andrew, Chapter 8: VelocImmune: Immunoglobulin Variable Region Humanized Mice, Recombinant Antibodies for Immunotherapy, Part III, 14 pages (2009). [cited by applicant]
Murphy, Andrew, Making the VelocImmune Mouse Using VelociGene Technology, Human Antibodies & Hybridomas, 31 pages (May 10-12, 2006). [cited by applicant]
Murphy, D., BAC-based Modifications of the Mouse Genome: The Big and the Backward, Wellcome Trust Advanced Course: Genetic Manipulation of ES Cells, 58 pages (2009). [cited by applicant]
Murphy, K., The Generation of Lymphocyte Antigen Receptors, Janeway's Immunobiology, 8th Edition, New York: Garland Science, Chapter 5, Sections 5-1 to 5-4, pp. 158-162 (2012). [cited by applicant]
Murphy, Kenneth. [cited by applicant]
Murphy, L. and Silha, J., Unexpected and unexplained phenotypes in transgenic models, Growth Horm IGF Res., 10(5):233-235 (2000). [cited by applicant]
Nagle (2007) Regeneron helps make Sanofi VelocImmune to its “weak pipeline”, <http://www.outsourcing-pharma.com/Preclinical-Research/Regeneron-helps-make-Sanofi-VelocImmune-to-its-weak-pipeline>—Published Dec. 3, 2007. [cited by applicant]
Nakanishi, T. et al., Selective Passage Through the Uterotubal Junction of Sperm from a Mixed Population Produced by Chimeras of Calmegin-Knockout and Wild-Type Male Mice, Biology of Reproduction, 71:959-965 (2004). [cited by applicant]
News In Brief Article (2007) Big Pharma vies for mice, [cited by applicant]
Nicholson, I.C. et al., Antibody Repertoires of Four- and Five-Feature Translocus Mice Carrying Human Immunoglobulin Heavy Chain and kappa and lambda light chain Yeast Artificial Chromosomes. Journal of Immunology 163(1… [cited by applicant]
Niemann, H. et al., Transgenic farm animals: present and future, Review of Science Technology, 24(1):285-298 (2005). [cited by applicant]
Nishimura, H. et al., Analysis of Loss of Adhesive Function in Sperm Lacking Cyritestin or Fertilin β, Developmental Biology, 233:204-213 (2001). [cited by applicant]
Nishimura, H. et al., Identification of an ADAM2-ADAM3 Complex on the Surface of Mouse Testicular Germ Cells and Cauda Epididymal Sperm, The Journal of Biological Chemistry, 282(24):17900-17907 (2007). [cited by applicant]
Nishimura, H. et al., Possible Function of the ADAM1a/ADAM2 Fertilin Complex in the Appearance of ADAM3 on the Sperm Surface, The Journal of Biological Chemistry, 279(33):34957-34962 (2004). [cited by applicant]
Nitschke, L. et al., Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage, Journal of Immunology, 166(4):2540-52 (2001). [cited by applicant]
Notice of Opposition to a European Patent for EP2550363, 28 pages (Dec. 10, 2014). [cited by applicant]
Oberdoerffer, P. et al., Unidirectional Cre-mediated genetic inversion in mice using the mutant loxP pair lox66/lox71, Nucleic Acids Research, 31(22)(e140): 1-7 (2003). [cited by applicant]
Office Action for U.S. Appl. No. 13/716,238, 7 pages (Jan. 4, 2016). [cited by applicant]
Office Action for U.S. Appl. No. 13/951,996, 7 pages (Dec. 17, 2015). . [cited by applicant]
Office Action for U.S. Appl. No. 14/137,902, 23 pages (Oct. 30, 2015). . [cited by applicant]
Office Action for U.S. Appl. No. 14/818,162, 30 pages (Dec. 11, 2015). [cited by applicant]
Opinion & Order between Regeneron Pharmaceuticals, Inc. and Merus B.V., 114 pages (Nov. 2, 2015). [cited by applicant]
Opponent Final Submissions for EP2550363, 15 pages (Jan. 27, 2017). [cited by applicant]
Paris, D.B. and Stout, T.A, Equine embryos and embryonic stem cells: defining reliable markers of pluripotency, Theriogenology 74(4):516-524 (2010). [cited by applicant]
Parng, C.L. et al., Gene conversion contributes to lg light chain diversity in cattle, The Journal of Immunology 157(12):5478-5486 (1996). [cited by applicant]
Pasqualini, R. and Arap, W., Hybridoma-free generation of monoclonal antibodies, Proceedings of the National Academy of Sciences USA, 101(1):257-259 (2004). [cited by applicant]
Patent Prosecution History of U.S. Appl. No. 13/166,200, filed Jun. 22, 2011. [cited by applicant]
Patentee Final Submissions for EP12716101.6, 4 pages (Jan. 27, 2017). [cited by applicant]
Pereira, B. et al., Cardiolipin binding a light chain from lupus-prone mice, Biochemistry, 37(5):1430-7 (1998). [cited by applicant]
Perez, M. et al., Primary cutaneous B-cell Lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments, British Journal of Dermatopathology, 162:611-… [cited by applicant]
Peterson, Norman C., Advances in Monoclonal Antibody Technology: Genetic Engineering of Mice, Cells, and Immunoglobulins, ILAR Journal, 46(3):314-319 (2005). [cited by applicant]
Petitte, J.N. et al., Avian pluripotent stem cells, Mech. of Develop. 121(9):1159-1168 (2004). [cited by applicant]
Pettersson, S. et al., A second B cell-specific enhancer 3′ of the immunoglobulin heavy-chain locus, Nature, 344(6262):165-168 (1990). [cited by applicant]
Pizzari, T. and Foster, K., Sperm Sociality: Cooperation, Altruism, and Spite, PLoS Biology, 6(5)(e130):0925-0931 (2008). [cited by applicant]
Popov, A. et al., Assembly and extension of yeast artificial chromosomes to build up a large locus, Gene, 177:195-201 (1996). [cited by applicant]
Popov, et al., A Human Immunoglobulin I locus is Similarly Well Expressed in Mice and Humans, J. Exp. Med., 189(10):1611-1619(1999). [cited by applicant]
Pos, W. et al., VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenia purpura, Journal of Thrombosis and Haemostatis, 7:421-428 (2008). [cited by applicant]
Poueymirou, W. et al., F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses, Nature Biotechnology, 25(1):91-99 (2007). [cited by applicant]
Preliminary Opinion of Opposition Division on EP 2550363, 24 pages, Jul. 29, 2016. [cited by applicant]
Primakoff, P. and Myles, D., The ADAM gene family: surface proteins with adhesion and protease activity, Trends Genet, 16(2):83-87 (2000). [cited by applicant]